β2 Integrins are characteristically absent in acute promyelocytic leukemia and rapidly upregulated in vivo upon differentiation with all-trans retinoic acid

Leukemia Research

Volumn 31, Issue 1, 2007, Pages 49-57

  Wu, Jamie J ^a   Cantor, Alan ^a   Moscinski, Lynn C ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

2 Integrin; Acute promyelocytic leukemia; Adhesion proteins; All trans retinoic acid; Differentiation; Flow cytometry

Indexed keywords

BETA2 INTEGRIN; CD11B ANTIGEN; CD34 ANTIGEN; GLYCOPROTEIN P 15095; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PADGEM PROTEIN; RETINOIC ACID; STEM CELL FACTOR RECEPTOR; ANTINEOPLASTIC AGENT; CD18 ANTIGEN; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY;

ARTICLE; BLAST CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKEMIA CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; UPREGULATION; ANALYSIS OF VARIANCE; BLOOD; BONE MARROW CELL; CELL DIFFERENTIATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; KARYOTYPING; PATHOLOGY; PREDICTION AND FORECASTING; RECURRENT DISEASE; RETROSPECTIVE STUDY;

ANALYSIS OF VARIANCE; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD18; ANTINEOPLASTIC AGENTS; BONE MARROW CELLS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KARYOTYPING; LEUKEMIA, PROMYELOCYTIC, ACUTE; LEUKOCYTE COUNT; PREDICTIVE VALUE OF TESTS; RECURRENCE; RETROSPECTIVE STUDIES; TRETINOIN;

EID: 33750739229     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.04.012     Document Type: Article

References (33)

1. Deguchi T., and Komada Y. Homing-associated cell adhesion molecule (H-CAM/CD44) on human CD34+ hematopoietic progenitor cells. Leuk Lymphoma 40 (2000) 25-37
2. Simmons P.J., Zannettino A., Gronthos A., and Leavesly D.I. Potential adhesion mechanisms for localization of hematopoietic progenitors to bone marrow stroma. Leuk Lymphoma 12 (1994) 353-363
3. Teixido J., Hemler M.E., Greenberger J.S., and Anklesia P. Role of β1 and β2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma. J Clin Invest 90 (1992) 358-367
4. Simmons P.J., Masinovsky B., Longenecker B.M., Berenson R., Torok-Storb B., and Gallitin W.M. Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 80 (1992) 388-395
5. Liseveld J.L., Frediani K.E., Harbol A.W., DiPersio J.F., and Abboud C.N. Characterization of the adherence of normal and leukemic CD34+ cells and endothelial monolayers. Leukemia 8 (1994) 2111-2117
6. Cavenagh J.D., Gordon-Smith E.C., Gibson F.M., and Gordon M.Y. Acute myeloid leukemia blast cells bind to human endothelium in vitro utilizing E-selectin and vascular cell adhesion molecule-1 (VCAM-1). Br J Haematol 85 (1993) 285-291
7. Keating A. Biology of acute myeloid leukemia: the role of stroma. Acute Myeloid Leukemia (2002), American Society of Hematology Education Program Book Seattle: American Society of Hematology p. 73-79
8. Wison J.G. Adhesive interactions in hemopoieis. Acta Haematol 97 (1997) 6-12
9. Bruserud O., and Ulvestad E. Expression and release of adhesion molecules by human acute myelogenous leukemia blasts. Leuk Res 23 (1999) 149-157
10. Locker G.J., Stoiser B., Losert H., Wenzel C., Ohler L., Kabrna E., et al. Decrease of circulating hematopoietic progenitor cells during interleulin-2 treatment is associated with an increase of vascular cell adhesion molecule-1, a critical molecule for progenitor cell adhesion. Leuk Lymphoma 39 (2000) 355-364
11. Carlos T.M., and Harlan J.M. Leukocyte-endothelial adhesion molecules. Blood 84 (1994) 2068-2101
12. Alon R., Fuhlbrigge R.L., Finger E.B., and Springer T.A. Interactions through l-selectin between leukocytes and adherent leukocytes nucleate rolling adhesions on selectins and VCAM-1 in shear flow. J Cell Biol 135 (1996) 849-865
13. Liesveld J.L. Expression and function of adhesion receptors in acute myelogenous leukemia: parallels with normal erythroid and myeloid progenitors. Acta Haematol 97 (1997) 53-62
14. Stucki A., Rivier A.S., Gikic M., Monai N., Schapira M., and Spertini O. Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination. Blood 97 (2001) 2121-2129
15. Denkers I.A.M., de Jong-de Boer T.J.M., Beelen R.H.J., Ossenkoppele G.J., Nauta J.J.P., and Langenhuijsen M.M.A.C. Adhesive capacity of human long-term bone marrow cultures from normals and patients with acute myeloid leukemia: the influence of adhesion molecules. Leuk Res 17 (1993) 255-261
16. Vila L., Thomas X., Campos L., Sabido O., and Archimbaud E. Expression of VLA molecules on acute leukemia cells: relationship with disease characteristics. Exp Hematol 23 (1995) 514-518
17. Thomas X., Anglaret B., Bailly M., Maritaz O., Magaud J.P., and Archimbaud E. Differential adhesiveness between blood and marrow leukemic cells having similar pattern of VLA adhesion molecule expression. Leuk Res 22 (1998) 953-960
18. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues (2001), IARC Press, Lyon 96
19. Gaidano G., Bergui L., Schena M., Gaboli M., Cremona O., Marchisio P.C., et al. Integrin distribution and cytoskeleton organization in normal and malignant monocytes. Leukemia 4 (1990) 682-687
20. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues (2001), IARC Press, Lyon 84-86
21. Rizzatti E.G., Garcia A.B., Portieres F.L., Silva D.E., Martins S.L.R., and Falcao R.P. Expression of CD117 and CD11b in bone marrow can differentiate acute promyelocytic leukemia from recovering benign myeloid proliferation. Am J Clin Pathol 118 (2002) 31-37
22. Paietta E. Expression of cell-surface antigens in acute promyelocytic leukaemia. Best Pract Res Clin Haematol 16 (2003) 369-385
23. Exner M., Thalhammer R., Kapiotis S., Mitterbauer G., Knobl P., Haas O.A., et al. The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): does it prove true for the M3-variant. Cytometry (Comm Clin Cytometry) 42 (2000) 106-109
24. Paietta E., Goloubeva O., Neuberg D., Bennett J.M., Gallagher R., Racevskis J., et al., the Eastern Cooperative Oncology Group. A surrogate marker profile for PML/RARAα expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes. Cytometry Part B (Clinical Cytometry) 59B (2004) 1-9
25. Larson R.S., Brown D.C., and Sklar L.A. Retinoic acid induces aggregation of the acute promyelocytic leukemia cell line NB-4 by utilization of LFA-1 and ICAM-2. Blood 90 (1997) 2747-2756
26. Yang L., Zhao H., Li S.W., Ahrens K., Collins C., Eckenrode S., et al. Gene expression profiling during all-trans retinoic acid-induced cell differentiation of acute promyelocytic leukemia cells. J Mol Diagn 5 (2003) 212-221
27. Di Noto R., Lo Pardo C., Schiavone E.M., Ferrara F., Manzo C., Vacca C., et al. All-trans retinoic acid (ATRA) and the regulation of adhesion molecules in acute myeloid leukemia. Leuk Lymphoma 21 (1996) 201-209
28. Thomas X., Anglaret B., Campos L., Thiebaut A., Sabido O., Bailly M., et al. Expression of β1 integrins and pseudo-immunoglobulins on acute promyelocytic leukemia cells and its modifications during in vitro differentiation. Leuk Res 22 (1998) 61-68
29. Degos L., Dombret H., Chomienne C., Daniel M.T., Miclea J.M., Chastang C., et al. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 85 (1995) 2643-2653
30. Kanamaru A., Takemoto Y., Tanimoto M., Murakami H., Asou N., Kobayashi T., et al., the Japan Adult Leukemia Study Group. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Blood 85 (1995) 1202-1206
31. Castaigne S., Chomienne C., Daniel M.T., Ballerini P., Berger R., Fenaux P., et al. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukaemia. I. Clinical results. Blood 76 (1990) 1704-1709
32. Frankel S.R., Eardley A., Lauwers G., Weiss M., and Warrell Jr. P. The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann Intern Med 117 (1992) 292-296
33. Sham R.L., Phatak P.D., Belanger K.A., Braggins C., and Packman C.H. Functional characteristics of mature granulocytes in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid. Leuk Res 19 (1995) 505-511